Work

MA12.08 Chemotherapy plus EGFR TKIs or Bevacizumab versus Chemotherapy Alone in SCLC-Transformed EGFR-Mutant Lung Adenocarcinoma

Year: 2021

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2021.01.259

Authors: C. Zhang, S. Zhang, Y. Yao, Y. Gao, J. Huang, K. Peng, Q. Gao, H. Chen, C. Xu, X. Zhang, Y. Wu, J. Yang

Institutions: Southern Medical University, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, South China University of Technology

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3138071985

Cites:

Cited by: 8

Related to: 10